Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington's disease.

MLA

Byrne, Lauren M., et al. “Evaluation of Mutant Huntingtin and Neurofilament Proteins as Potential Markers in Huntington’s Disease.” Science Translational Medicine, vol. 10, no. 458, Sept. 2018. EBSCOhost, https://doi.org/10.1126/scitranslmed.aat7108.

APA

Byrne, L. M., Rodrigues, F. B., Johnson, E. B., Wijeratne, P. A., De Vita, E., Alexander, D. C., Palermo, G., Czech, C., Schobel, S., Scahill, R. I., Heslegrave, A., Zetterberg, H., & Wild, E. J. (2018). Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington’s disease. Science Translational Medicine, 10(458). https://doi.org/10.1126/scitranslmed.aat7108

Chicago

Byrne, Lauren M, Filipe B Rodrigues, Eileanor B Johnson, Peter A Wijeratne, Enrico De Vita, Daniel C Alexander, Giuseppe Palermo, et al. 2018. “Evaluation of Mutant Huntingtin and Neurofilament Proteins as Potential Markers in Huntington’s Disease.” Science Translational Medicine 10 (458). doi:10.1126/scitranslmed.aat7108.